December 10, 2019
/
CCSN News
CCSN’s Fifth Ontario All-Party Cancer Caucus Meeting Focused on Chronic Pain Issues
On December 5, 2019, Canadian Cancer Survivor Network hosted its fifth Ontario All-party Cancer Caucus at Queen’s Park. The cancer rehabilitation series focused on cancer survivor rehabilitation and cancer pain management, and featured an in-depth conversation on cancer rehabilitative services in Ontario, and treating chronic patient pain in today’s healthcare.
Read More
Bladder Cancer Support Group in Ottawa
Canadian Cancer Survivor Network’s Mona Forrest visited the Bladder Cancer Support Group in Ottawa November 28 at the invitation of Support Group Coordinator Snookie Lomow.
Read More
A special Legislative Reception at Queen’s Park
Our morning reception in the legislative dining room at Queen’s Park on November 7, 2019 was attended by nearly 100 patients, caregivers, survivors, cancer patient groups, MPPs, including three ministers and several staffers, and others.
Read More
Meet CCSN’s Partnership & Fundraising Manager
Earlier this month, CCSN welcomed Owen Brady, our new Partnership & Fundraising Manger. Having multiple years of experience working in the non-profit sector, Owen brings a wealth of expertise in fundraising, partnership management, and community engagement to his role.
Read More
November 21, 2019
/
CCSN News
Coming soon – The Science of Cancer online course!
The Canadian Cancer Survivor Network has designed an online course which will help prepare you for a variety of exciting opportunities to have your own voice heard within healthcare discourses and practices.
Read More
October 31, 2019
/
CCSN News
Nova Scotia Becomes First Province to Adopt Software to Assess and Report Breast Density
Information about breast density is an important part of breast cancer screening and ensuring early detection and treatment. That is why it will now be automatically included in a woman’s...
Read More
October 10, 2019
/
CCSN News
Notice: Prescription Drug List (PDL): Multiple Additions
Date: October 7, 2019 Our file number: 19-119291-196 The purpose of this Notice of Amendment is to notify about the additions of acalabrutinib, galcanezumab, larotrectinib, mannitol, neratinib, niraparib, ravulizumab, romosozumab,...
Read More
October 2, 2019
/
CCSN News
An Update from Clinical Trials Ontario
Clinical Trials Ontario (CTO) has been working with health charities and patient organizations like CCSN to build tools and resources about clinical trials that are informed by and meet the...
Read More
October 2, 2019
/
CCSN News
Where Do Canada’s MP Candidates Stand on Cancer Issues?
Ahead of the federal election, CCSN believes in the critical importance of raising key issues related to the mission of creating and maintaining the best standard of care for cancer...
Read More
October 2, 2019
/
CCSN News
Patient Group Engagement in Public Policy: the Convergence of Experience, Influence and Opportunity
CCSN President & CEO Jackie Manthorne was one of several speakers at the Ontario Lung Association Breathing Policy Forum on Patient Engagement in Public Policy held in Toronto on Sept....
Read More